Glutamine-Loaded Liposomes: Preliminary Investigation, Characterization, and Evaluation of Neutrophil Viability
Tóm tắt
Glutamine has received attention due to its ability to ameliorate the immune system response. Once conventional liposomes are readily recognized and captured by immune system cells, the encapsulation of glutamine into those nanosystems could be an alternative to reduce glutamine dosage and target then to neutrophils. Our goals were to nanoencapsulate glutamine into conventional liposomes (Gln-L), develop an analytical high-performance liquid chromatography (HPLC) method for its quantification, and evaluate the viability of neutrophils treated with Gln-L. Liposomes were prepared using the thin-film hydration technique followed by sonication and characterized according to pH, mean size, zeta potential, and drug encapsulation efficiency (EE%). We also aimed to study the effect of liposomal constituent concentrations on liposomal characteristics. The viability of neutrophils was assessed using flow cytometry after intraperitoneal administration of free glutamine (Gln), Gln-L, unloaded-liposome (UL), and saline solution as control (C) in healthy Wistar rats. The selected liposomal formulation had a mean vesicle size of 114.65 ± 1.82 nm with a polydispersity index of 0.30 ± 0.00, a positive surface charge of 36.30 ± 1.38 mV, and an EE% of 39.49 ± 0.74%. The developed chromatographic method was efficient for the quantification of encapsulated glutamine, with a retention time at 3.8 min. A greater viability was observed in the group treated with glutamine encapsulated compared to the control group (17%), although neutrophils remain viable in all groups. Thus, glutamine encapsulated into liposomes was able to increase the number of viable neutrophils at low doses, thereby representing a promising strategy for the treatment of immunodeficiency conditions.
Tài liệu tham khảo
Newsholme P, Lima MMR, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003;36:153–63.
Labow BI, Souba WW. Glutamine. World J Surg. 2000;24:1503–13. doi:10.1007/s002680010269.
Albino Junior W, Alberto C, Taliari K, Cancelliero KM. Suplementação com glutamina melhora as reservas de glicogênio de músculos de ratos tratados com dexametasona. Rev Bras Educ Fís Esp. 2004;18:283–91.
Cruzat VF, Petry ER, Tirapegui J. Glutamina : aspectos bioquímicos, metabólicos, moleculares e suplementação. Rev Bras Med Esporte. 2009;15:392–7.
Harris RC, Hoffman JR, Allsopp A, Routledge NBH. L-glutamine absorption is enhanced after ingestion of L-alanylglutamine compared with the free amino acid or wheat protein. Nutr Res. 2012;32:272–7. doi:10.1016/j.nutres.2012.02.003.
Gleeson M. Dosing and efficacy of glutamine supplementation in human exercise and sport training. J Nutr. 2008;138:2045S–9S.
Ardawi MSM, Newsholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem J. 1983;212:835–42.
Curi TCP, Melo MP, Azevedo RB, Zorn TMT, Curi R. Glutamine utilization by rat neutrophils: presence of phosphate-dependent glutaminase. Am J Physiol Cell Physiol. 1997;273:1124–9.
Pithon-Curi TC, Schumacher RI, Freitas JJS, Lagranha C, Newsholme P, Palanch AC, et al. Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol. 2003;284:C1355–61. doi:10.1152/ajpcell.00224.2002.
Lagranha CJ, Senna SM, Lima TM, Silva EPP, Doi SQ, Curi R, et al. Beneficial effect of glutamine on exercise-induced apoptosis of rat neutrophils. Med Sci Sports Exerc. 2004;36:210–7. doi:10.1249/01.MSS.0000113490.98089.B1.
Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, et al. Molecular mechanisms of glutamine action. J Cell Physiol. 2005;204:392–401. doi:10.1002/jcp.20339.
Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297–309.
Furst P. New developments in glutamine delivery. J Nutr. 2001;131:2562–8.
Lagranha CJ, Levada-Pires AC, Sellitti DF, Procopio J, Curi R, Pithon-Curi TC. The effect of glutamine supplementation and physical exercise on neutrophil function. Amino Acids. 2008;34:337–46. doi:10.1007/s00726-007-0560-x.
Fan Y, Yu J, Kang W, Zhang Q. Effects of glutamine supplementation on patients undergoing abdominal surgery. Chin Med Sci J. 2009;24:55–9. doi:10.1016/S1001-9294(09)60060-2.
Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr. 2001;131:2543–9.
Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond). 2003;104:275–82. doi:10.1042/CS20020198.
Alba-Loureiro TC, Ribeiro RF, Zorn TMT, Lagranha CJ. Effects of glutamine supplementation on kidney of diabetic rat. Amino Acids. 2010;38:1021–30. doi:10.1007/s00726-009-0310-3.
Galera SC, Fechine FV, Teixeira MJ, Coelho ZCB, Vasconcelos RC, Vasconcelos PRL. The safety of oral use of L-glutamine in middle-aged and elderly individuals. Nutrition. 2010;26:375–81. doi:10.1016/j.nut.2009.05.013.
D’Souza R, Powell-Tuck J. Glutamine supplements in the critically ill. J R Soc Med. 2004;97:425–7. doi:10.1258/jrsm.97.9.425.
O’Neil MJ. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. 6th ed. New Jersey: Merck; 2006.
Brandl M, Gregoriadis G. Entrapment of haemoglobin into liposomes by the behaviour. Biochim Biophys Acta. 1994;1196:65–75.
Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–60. doi:10.1038/nrd1632.
Lira MCB, Ferraz MS, Silva DGVC, Cortes ME, Teixeira KI, Caetano NP, et al. Inclusion complex of usnic acid with β-cyclodextrin: characterization and nanoencapsulation into liposomes. J Incl Phenom Macrocycl Chem. 2009;64:215–24. doi:10.1007/s10847-009-9554-5.
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–7.
Lagranha CJ, Alba-Loureiro TC, Martins EF, Pithon-Curi TC, Curi R. Neutrophil fatty acid composition: effect of a single session of exercise and glutamine supplementation. Amino Acids. 2008;35:243–5. doi:10.1007/s00726-007-0561-9.
Cadena PG, Pereira MA, Cordeiro RBS, Cavalcanti IMF, Barros Neto B, Pimentel MDCCB, et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta. 2013;1828:309–16. doi:10.1016/j.bbamem.2012.10.022.
Caddeo C, Teskac K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm. 2008;363:183–91. doi:10.1016/j.ijpharm.2008.07.024.
Wieber A, Selzer T, Kreuter J. Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. Eur J Pharm Biopharm. 2012;80:358–67. doi:10.1016/j.ejpb.2011.11.008.
Mendonça EAM, Lira MCB, Rabello MM, Cavalcanti IMF, Galdino SL, Pitta IR, et al. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes. AAPS PharmSciTech. 2012;13:1355–66. doi:10.1208/s12249-012-9853-9.
Hamilton JG, Comai K. Separation of neutral lipids and free fatty acids by high-performance liquid chromatography using low wavelength ultraviolet detection. J Lipid Res. 1984;25:1142–8.
Koller M, Eckert H. Derivatization of peptides for their determination by chromatographic methods. Anal Chim Acta. 1997;352:31–59.
Snowden MK, Baxter JH, Bergana MM, Reyzer I, Pound V. Stability of n-acetylglutamine and glutamine in aqueous solution and in a liquid nutritional product by an improved HPLC method. J Food Sci. 2002;67:384–9.
Chorilli M, Salgado HRN, Santo FDS, Silva LM. Validation of a HPLC method for determination of glutamine in food additives using post-column derivatization. AJAC. 2012;3:113–7. doi:10.4236/ajac.2012.32016.
Lagranha CJ, Lima TM, Senna SM, Doi SQ, Curi R, Pithon-Curi TC. The effect of glutamine supplementation on the function of neutrophils from exercised rats. Cell Biochem Funct. 2005;23:101–7. doi:10.1002/cbf.1192.
Szebeni J, Muggia F, Gabizon A, Barenholz Y. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev. 2011;63:1020–30. doi:10.1016/j.addr.2011.06.017.
Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr. 2001;131:2515–22.